Concepedia

Yiming Zhong

YZ

33

Publications

3.1K

Citations

23

H-Index

2011

Active since

Affiliations

The Ohio State University(Current)

Ruijin Hospital

Central South University

Shanghai Jiao Tong University

Xiangya Hospital Central South University

Yiming Zhong is an author at The Ohio State University specializing in medicine, engineering, and nanomedicine.

ORCID

Top concepts

Publications per year

2011–2024

33

Publications

33

Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes

Jason A. Dubovsky, Kyle A. Beckwith, Gayathri Natarajan et al. · Blood · 2013 · 783 citations · Full text

Selective inhibitors of nuclear export show that CRM1/XPO1 is a target in chronic lymphocytic leukemia

Rosa Lapalombella, Qingxiang Sun, Katie Williams et al. · Blood · 2012 · 293 citations · Full text

Prolonged lymphocytosis during ibrutinib therapy is associated with distinct molecular characteristics and does not indicate a suboptimal response to therapy

Jennifer A. Woyach, Kelly A. Smucker, Lisa L. Smith et al. · Blood · 2014 · 273 citations · Full text

Enhancing Mechanical Properties of Silk Fibroin Hydrogel through Restricting the Growth of β-Sheet Domains

Dihan Su, Yao Meng, Jie Liu et al. · ACS Applied Materials & Interfaces · 2017 · 248 citations

Ibrutinib treatment ameliorates murine chronic graft-versus-host disease

Jason A. Dubovsky, Ryan Flynn, Jing Du et al. · Journal of Clinical Investigation · 2014 · 198 citations · Full text

Rows per page

1–5 of 33